These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 2975585

  • 21. Testing times for women in body lab.
    Bacon W.
    Lamp; 1983 May; 40(3):38-40. PubMed ID: 6228701
    [Abstract] [Full Text] [Related]

  • 22. Depo-Provera--missing the point?
    Fennessy S.
    Aust Fam Physician; 1988 Oct; 17(10):839-40. PubMed ID: 2977094
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. FDA gives final approval to Depo amid concerns over safety, cost and coercion.
    Wash Memo Alan Guttmacher Inst; 1992 Nov 12; (17):2-3. PubMed ID: 12344620
    [Abstract] [Full Text] [Related]

  • 26. The Depo-Provera public hearing.
    Dening FC.
    Midwives Chron; 1983 Jul 12; 96(1146):246. PubMed ID: 6225940
    [No Abstract] [Full Text] [Related]

  • 27. Depo-Provera update.
    PIACT Prod News; 1982 Dec 12; 4(3):1, 4. PubMed ID: 12264595
    [Abstract] [Full Text] [Related]

  • 28. FDA board investigates Depo-Provera safety.
    Contracept Technol Update; 1983 Mar 12; 4(3):25-7. PubMed ID: 12266161
    [Abstract] [Full Text] [Related]

  • 29. [Prolonged use of medroxyprogesterone acetate for contraception].
    Pena Delgado J, Aleman Herrera M, Baez Reyes A.
    Sem Med Mex; 1981 Jun 26; 98(11):331-50. PubMed ID: 12279435
    [Abstract] [Full Text] [Related]

  • 30. Use of a long-acting injectable contraceptive in a postpartum family planning program.
    Mcdaniel EB, Pardthaisong T.
    Asian J Med; 1973 Apr 26; 9(4):133-5. PubMed ID: 12262537
    [Abstract] [Full Text] [Related]

  • 31. Depo-Provera: an injectable contraceptive.
    Wigington S.
    Nurs Times; 1973 Apr 26; 77(42):1794-8. PubMed ID: 6458020
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. What is breast cancer risk with Depo-Provera?
    Contracept Technol Update; 1992 Jan 26; 13(1):15-6. PubMed ID: 12343459
    [Abstract] [Full Text] [Related]

  • 34. The case for depo provera.
    Cooling H, Christopher E.
    Health Visit; 1989 Oct 26; 62(10):320. PubMed ID: 2530193
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Update on Depo-Provera.
    Sapire KE.
    S Afr Med J; 1992 May 02; 81(9):444-5. PubMed ID: 1533472
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Depo-Provera--antineoplastic agents which is also a contraceptive].
    Tylleskär J.
    Jordemodern; 1988 Mar 02; 101(3):55-8. PubMed ID: 2967271
    [No Abstract] [Full Text] [Related]

  • 39. Frequent urination and Depo-Provera. Ask the experts.
    Kaunitz A, Nelson A, Wysocki S, Schnare S.
    Contracept Technol Update; 1998 Dec 02; 19(12):160-1. PubMed ID: 12321808
    [Abstract] [Full Text] [Related]

  • 40. 3-month contraceptive injection approved.
    FDA Med Bull; 1993 Mar 02; 23(1):6-7. PubMed ID: 12318115
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.